Inve US ▾
ENENOV

Enovis (ENOV) Q2 FY26 earnings call

Earnings call· Jun 2026 (Q2 FY26)· Health Care· Aug 6, 2026

Source: earnings call transcript

Enovis delivered robust Q2 FY26 results, driven by strong organic growth in Recon and P&R segments, alongside significant adjusted gross margin expansion. The company reaffirmed its full-year guidance, navigating headwinds from international conflicts and inflation through operational productivity and new product scaling. Management emphasized continued focus on commercial execution, innovation, and financial discipline, including debt reduction and free cash flow generation, while evaluating future portfolio advancements.

You’re reading a preview. Opening the full call uses 1 concall credit.

Sign in to use your monthly call allowance.

Inve summary of the company's earnings call; see how call summaries are prepared. Not investment advice.